These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29111425)

  • 1. Transcranial sonographic findings may predict prognosis of gastroprokinetic drug-induced parkinsonism.
    Oh YS; Kwon DY; Kim JS; Park MH; Berg D
    Parkinsonism Relat Disord; 2018 Jan; 46():36-40. PubMed ID: 29111425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.
    Toomsoo T; Liepelt-Scarfone I; Berg D; Kerner R; Pool AH; Kadastik-Eerme L; Rubanovits I; Asser T; Taba P
    Ultrasound Med Biol; 2019 Jan; 45(1):122-128. PubMed ID: 30482710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
    Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
    Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is transcranial sonography useful to distinguish drug-induced parkinsonism from Parkinson's disease?
    Mahlknecht P; Stockner H; Kiechl S; Willeit J; Rastner V; Gasperi A; Rungger G; Poewe W; Seppi K
    Mov Disord; 2012 Aug; 27(9):1194-6. PubMed ID: 22692761
    [No Abstract]   [Full Text] [Related]  

  • 5. Transcranial brain sonography in Parkinson's disease with restless legs syndrome.
    Kwon DY; Seo WK; Yoon HK; Park MH; Koh SB; Park KW
    Mov Disord; 2010 Jul; 25(10):1373-8. PubMed ID: 20544813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.
    Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Tan YY; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Chen SD
    J Parkinsons Dis; 2018; 8(2):333-340. PubMed ID: 29614699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
    Li DH; Zhang LY; Hu YY; Jiang XF; Zhou HY; Yang Q; Kang WY; Liu J; Chen SD
    Parkinsonism Relat Disord; 2015 Aug; 21(8):923-8. PubMed ID: 26066091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
    Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
    Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperechogenicity of the substantia nigra in Parkinson's disease.
    Ressner P; Skoloudík D; Hlustík P; Kanovský P
    J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson's disease: a Chinese population-based study.
    Li T; Shi J; Qin B; Fan D; Liu N; Ni J; Zhang T; Zhou H; Xu X; Wei M; Zhang X; Wang X; Liu J; Wang Y; Tian J
    Neurol Sci; 2020 Mar; 41(3):661-667. PubMed ID: 31754876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations.
    Okawa M; Miwa H; Kajimoto Y; Hama K; Morita S; Nakanishi I; Kondo T
    Intern Med; 2007; 46(18):1527-31. PubMed ID: 17878638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up study.
    Alonso-Canovas A; Lopez-Sendon Moreno JL; Buisan J; Sainz de la Maza S; Costa-Frossard L; Garcia-Ribas G; de Felipe-Mimbrera A; Matute-Lozano MC; Zarza Sanz B; Toledano Delgado R; Corral I; Masjuan J; Martinez-Castrillo JC
    J Neurol; 2018 Oct; 265(10):2363-2369. PubMed ID: 30116942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcranial color-coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism.
    Tsai CF; Wu RM; Huang YW; Chen LL; Yip PK; Jeng JS
    J Neurol; 2007 Apr; 254(4):501-7. PubMed ID: 17401518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study).
    Prati P; Bignamini A; Coppo L; Naldi A; Comi C; Cantello R; Gusmaroli G; Walter U
    J Neural Transm (Vienna); 2017 Jul; 124(7):869-879. PubMed ID: 28451942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new program for highly reproducible automatic evaluation of the substantia nigra from transcranial sonographic images.
    Blahuta J; Soukup T; Jelinkova M; Bartova P; Cermak P; Herzig R; Skoloudik D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Dec; 158(4):621-7. PubMed ID: 23640029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease.
    van de Loo S; Walter U; Behnke S; Hagenah J; Lorenz M; Sitzer M; Hilker R; Berg D
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1087-92. PubMed ID: 20543186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substantia nigra hyperechogenicity and brain ventricular size as biomarkers of early dementia with Lewy bodies.
    Planas-Ballvé A; Rios J; Gea M; Rabaneda-Lombarte N; Ispierto L; Grau L; Jiménez M; Cáceres C; Martínez S; Beyer K; Álvarez R; Pastor P; Vilas D
    Alzheimers Res Ther; 2024 Oct; 16(1):227. PubMed ID: 39407323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcranial sonography in the early and differential diagnosis of Parkinson's disease.
    Berg D
    J Neural Transm Suppl; 2006; (70):249-54. PubMed ID: 17017537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of transcranial sonography in clinically diagnosed patients with early stage Parkinson's disease: comparison with DAT PET scans.
    Liu P; Li X; Li FF; Ou-Yang QH; Zhang HX; Feng T
    Neurosci Lett; 2014 Oct; 582():99-103. PubMed ID: 25218716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.